News > February > 2012

29th February 2012

Simbec – Celebrating Long Term Expertise

Whilst the needs and challenges for sponsors continue to evolve (be they financial constraints, regulatory changes or scientific complexities) one constant solution through all this turmoil remains Simbec’s customised approach to meet specific challenges. For over 35 years Simbec has been providing customised solutions to the needs of our Sponsors helping them to reshape their…

27th February 2012

Evans gives his prescription for life sciences

Insider News Wales  Last updated: 21st Feb 2012 A strong Welsh brand, better commercialisation of research and a "focal point" in Wales are on biotech leader Sir Chris Evans’ prescription for life sciences in Wales. Evans, who chairs the Welsh Government’s Life Sciences Sector Panel, will outline the panel’s strategy at the BioWales 2012 conference…

20th February 2012

Prostate cancer patients in Wales to get breakthrough drug

By Madeleine Brindley, WalesOnline Feb 19 2012 MEN with advanced prostate cancer will get access to a new breakthrough treatment in Wales. The All-Wales Medicines Strategy Group (AWMSG) has approved the use of the abiraterone acetate for men with cancer which has spread beyond the prostate and is resistant to conventional hormone treatment (metastatic castration-resistant prostate…

09th February 2012

PKF (UK) LLP – Top Ten Tax Planning Tips for the Year End

Don’t miss out on opportunities to reduce your 2012 tax bill before the end of the tax year   The current tax year ends on 5 April 2012 so now is a good time to look at your finances. Here are some top tips of things to consider: • Use your personal allowances wisely Married…

08th February 2012

Acuitas Medical secures major investment to bring its proprietary fineSA

  South Wales UK-based Acuitas Medical Limited has completed a major seven figure funding round which will enable the company to accelerate its clinical validation and workflow integration programmes with disease signature biomarkers, initially for liver, lung, brain and bone pathologies. Latest research using the company’s patented fineSA software, conducted by Professor Diego Martin at…

06th February 2012

Swansea neuroscientist leads the way for national Epilepsy charity

By asiancorrespondent.com Professor Mark Rees, Chair of Neurology Research at Swansea University’s Institute of Life Science (ILS), has been selected to Chair the Scientific Advisory Committee at Epilepsy Research UK (ERUK). ERUK is the only national charity that funds independent research exclusively into the causes, treatment and prevention of epilepsy. Originally hailing from the Gwendraeth…

06th February 2012

Cardiff Medical School secure funding from Wellcome Trust

News Wales: Section Health | Published on 6 Feb 2012 Leading university neuroscience and immunology research which helps translate new knowledge into improved clinical practice and treatments for the benefit of patients is set to receive a £4.5M funding boost. Cardiff University has secured funding from the Wellcome Trust’s new Institutional Strategic Support Fund (ISSF) –…

02nd February 2012

MediWales award winners shortlisted at the Medilink UK Awards 2012

   We are proud to announce that following on from the MediWales Innovation Awards, Welsh companies have been shortlisted in four out of the five categories and we look forward to the results of our finalists on the night. If you would like to find out more about how to get involved with next year…